Skip to main content

In Vivo Preclinical Efficacy & Safety of CAR-T, -NK, and -Myeloid Based Therapies

Published Date

Technical Information Services Manager, Brian Soper, Ph.D., explores recent advances in CAR mediated strategies for human immuno-oncology. Recorded on 4-7-22